Who is sponsoring NCT05272137?

NCT05272137 is sponsored by Saluda Medical Pty Ltd.

What drugs are being tested in NCT05272137?

Interventions in NCT05272137: Evoke Spinal Cord Stimulation (SCS) System.

What condition does NCT05272137 study?

NCT05272137 studies Chronic Pain.

Is NCT05272137 still recruiting?

NCT05272137 is currently completed. Last updated 12 April 2023.

Last reviewed 2023-04-12 · How we verify

NCT05272137

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evoke Data Collection Study Germany

Completed Last updated 12 April 2023

What this trial tests

trial testing Evoke Spinal Cord Stimulation (SCS) System in Chronic Pain in 2 participants. Completed in 17 October 2022.

Timeline

4 February 2022

Primary endpoint
17 October 2022

17 October 2022

Quick facts

Lead sponsor	Saluda Medical Pty Ltd
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2
Start date	4 February 2022
Primary completion	17 October 2022
Estimated completion	17 October 2022
Sites	1 location across Germany

Drugs / interventions tested

Evoke Spinal Cord Stimulation (SCS) System

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

Saluda Medical Pty Ltd — full company profile →

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this multicentre study is to collect electrophysiological and device data from the Evoke Closed-Loop SCS system in the treatment of chronic pain of the trunk and/or limbs, in a real world setting under normal conditions of use.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

First evidence of a biomarker-based dose-response relationship in chronic pain using physiological closed-loop spinal cord stimulation.
Muller L, Pope J, Verrills P, Petersen E, et al · · 2025 · cited 15× · PMID 38508591 · DOI 10.1136/rapm-2024-105346
Durability of Evoked Compound Action Potential (ECAP)-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) in a Real-World European Chronic Pain Population.
Nijhuis H, Kallewaard JW, van de Minkelis J, Hofsté WJ, et al · · 2024 · cited 12× · PMID 38954217 · DOI 10.1007/s40122-024-00628-z
First Objective Evidence Characterizing Differences in Cervical and Thoracic Spinal Cord Neurophysiology Using ECAP-Controlled Closed-Loop Technology.
Goree JH, Nijhuis H, Smith GL, Petersen EA, et al · · 2025 · PMID 41066061 · DOI 10.1007/s40122-025-00782-y

Verify or expand the search:

Other trials of Evoke Spinal Cord Stimulation (SCS) System

Trials testing the same drug.

NCT06229470 — Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pai · NA · active not recruiting
NCT04662905 — Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain · NA · recruiting
NCT04319887 — ECAP-controlled, Closed-loop Stimulation to Treat Chronic Trunk and/or Limb Pain (ECAP) · NA · completed
NCT04627974 — Long-term Effectiveness, Safety, and Performance of the Evoke Closed-Loop SCS System to Treat Patients With Chronic Pain · active not recruiting

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Saluda Medical Pty Ltd trials

Trials by the same sponsor.

NCT06229470 — Clinical Utility of Neurophysiological Measurements of ECAP-controlled Closed-loop SCS to Guide Treatment of Chronic Pai · NA · active not recruiting
NCT06057480 — APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs · NA · completed
NCT04662905 — Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain · NA · recruiting
NCT04319887 — ECAP-controlled, Closed-loop Stimulation to Treat Chronic Trunk and/or Limb Pain (ECAP) · NA · completed
NCT04627974 — Long-term Effectiveness, Safety, and Performance of the Evoke Closed-Loop SCS System to Treat Patients With Chronic Pain · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05272137 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saluda Medical Pty Ltd
Last refreshed: 12 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05272137.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing